Ernexa Therapeutics Inc. Public Float
Ernexa Therapeutics Inc. (ERNA) had Public Float of $17.50 million as of 2025-06-30, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-13
- 2025-06-30: Entity Public Float $17.50M.
- 2024-06-30: Entity Public Float $8.90M.
- 2023-06-30: Entity Public Float $9.70M.
- 2022-06-30: Entity Public Float $23.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $17.50M 10-K · filed 2026-03-13 |
| 2024-06-30 | $8.90M 10-K · filed 2025-03-12 |
| 2023-06-30 | $9.70M 10-K/A · filed 2024-03-18 |
| 2022-06-30 | $23.80M 10-K · filed 2023-03-20 |
| 2021-06-30 | $694.00M 10-K/A · filed 2022-07-01 |
| 2020-06-30 | $5.30M 10-K · filed 2021-03-11 |
| 2019-06-28 | $6.40M 10-K · filed 2020-03-19 |
| 2018-06-30 | $7.40B 10-K · filed 2019-03-22 |
| 2017-06-30 | $11.20M 10-K · filed 2018-03-09 |
| 2016-06-30 | $12.10M 10-K · filed 2017-03-09 |
| 2015-06-30 | $16.30M 10-K · filed 2016-03-15 |
| 2014-06-30 | $37.50M 10-K · filed 2015-03-27 |
| 2013-06-28 | $20.70M 10-K · filed 2014-03-31 |
| 2012-06-30 | $7.10M 10-K · filed 2013-03-29 |
| 2011-06-30 | $24.67M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |